Eligi
Med
Base de datos
Seguridad
Sobre EligiMed
Contáctenos
Ensayos Clínicos de Enfermedades Infecciosas | EligiMed
Ensayos clínicos
887 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of a Single Infusion of Bezlotoxumab (MK-6072, Human Monoclonal Antibody to C. Difficile Toxin B) in Children Aged 1 to <18 Years Receiving Antibacterial Drug Treatment for C. Difficile Infection (MODIFY III)
Intervencional
Inicio: 27 de mar de 2018
ID: NCT03182907
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Multi-center Study to Establish the Efficacy and Safety of Ceftobiprole Medocaril Compared to Daptomycin in the Treatment of Staphylococcus Aureus Bacteremia, Including Infective Endocarditis
Intervencional
Inicio: 26 de ago de 2018
ID: NCT03138733
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Observer-Blind, Randomized, Controlled, Multicenter Study to Evaluate Safety, Tolerability, and Immunogenicity of Two Trivalent Subunit Inactivated Influenza Vaccines in Healthy Children Aged 3 to 8 Years, in Healthy Children/Adolescents Aged 9 to 17 Years,and in Healthy Adults Aged 18 to 64 Years
Intervencional
Inicio: 1 de abr de 2007
ID: NCT00464672
Completado
Fase 3
ClinicalTrials.gov
Adaptive Platform Treatment Trial for Outpatients With COVID-19 (Adapt Out COVID)
Intervencional
Inicio: 19 de ago de 2020
ID: NCT04518410
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Observer-Blind, Placebo-Controlled, Group-Sequential Study to Determine the Immunogenicity and Safety of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum in Healthy Third-trimester Pregnant Women; and Safety and Efficacy of Maternally Transferred Antibodies in Preventing RSV Disease in Their Infants
Intervencional
Inicio: 1 de dic de 2015
ID: NCT02624947
Activo, no recluta
ClinicalTrials.gov
Herramientas de apoyo al tratamiento de la tuberculosis: perfeccionamiento y evaluación de una aplicación móvil interactiva y monitorización directa de la adherencia en los resultados del tratamiento de la tuberculosis
Intervencional
Inicio: 17 de nov de 2020
ID: NCT04221789
Activo, no recluta
Fase 3
ClinicalTrials.gov
Estudio clínico de fase 3, aleatorizado, con control activo y doble ciego para evaluar la actividad antirretroviral, la seguridad y la tolerabilidad de doravirina/islatravir (DOR/ISL 100 mg/0,25 mg) una vez al día en participantes con infección por VIH-1 sin tratamiento previo
Intervencional
Inicio: 8 de mar de 2023
ID: NCT05705349
Anterior
1
...
44
45
Filtros
1